ArticleNeuro-oncology2026

Erratum to: Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.